Press release
Cervical Cancer Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Cervical Cancer Overview
Cervical cancer is a type of cancer that occurs in the cells of the cervix - the lower part of the uterus that connects to the vagina. Various strains of the human papillomavirus (HPV), a sexually transmitted infection, play a role in causing most cervical cancer. When exposed to HPV, the body's immune system typically prevents the virus from doing harm. In a small percentage of people, however, the virus survives for years, contributing to the process that causes some cervical cells to become cancer cells.
"Cervical Cancer Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cervical Cancer Market.
The Cervical Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Cervical Cancer Pipeline Report: https://www.delveinsight.com/report-store/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Cervical Cancer treatment therapies with a considerable amount of success over the years. Cervical Cancer Key players such as - Rubius Therapeutics, Nurix, PDS Biotechnology Corporation, Vaccibody AS, Roche, EMD Serono, Eli Lilly and Company, Akeso Biopharma, Regeneron Pharmaceuticals, and others, are developing therapies for the Cervical Cancer treatment
• Cervical Cancer Emerging therapies such as - RTX 321, DeTIL 0255, PDS 0101, VB10.16, Tiragolumab, Bintrafusp alfa, Gemcitabine, Cadonilimab, Cemiplima, and others are expected to have a significant impact on the Cervical Cancer market in the coming years.
• In September 2021, Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had accepted for priority review the supplemental Biologics License Application (sBLA) for PD-1 inhibitor Libtayo (cemiplimab-rwlc) to treat patients with recurrent or metastatic cervical cancer whose disease progressed on or after chemotherapy.
Cervical Cancer Pipeline Therapeutics Assessment
• Cervical Cancer Assessment by Product Type
• Cervical Cancer By Stage and Product Type
• Cervical Cancer Assessment by Route of Administration
• Cervical Cancer By Stage and Route of Administration
• Cervical Cancer Assessment by Molecule Type
• Cervical Cancer by Stage and Molecule Type
DelveInsight's Cervical Cancer Report covers around 70+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging Cervical Cancer Drugs Under Different Phases of Clinical Development Include:
• RTX 321: Rubius Therapeutics
• DeTIL 0255: Nurix
• PDS 0101: PDS Biotechnology Corporation
• VB10.16: Vaccibody AS
• Tiragolumab: Roche
• Bintrafusp alfa: EMD Serono
• Gemcitabine: Eli Lilly and Company
• Cadonilimab: Akeso Biopharma
• Cemiplimab: Regeneron Pharmaceuticals
Get a Free Sample PDF Report to know more about Cervical Cancer Pipeline Assessment- https://www.delveinsight.com/sample-request/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cervical Cancer Pipeline Analysis:
The Cervical Cancer pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the Cervical Cancer treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cervical Cancer Treatment.
• Cervical Cancer key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Cervical Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cervical Cancer market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Cervical Cancer product details are provided in the report. Download the Cervical Cancer pipeline report to learn more about the emerging Cervical Cancer therapies at:
https://www.delveinsight.com/sample-request/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Cervical Cancer Pipeline Market Drivers
• Increase in the incidence of oncological disease
• Large number of ongoing clinical trials
Cervical Cancer Pipeline Market Barriers
• High cost of therapy
• Side-effects associated
Scope of Cervical Cancer Pipeline Drug Insight
• Coverage: Global
• Key Cervical Cancer Companies: Rubius Therapeutics, Nurix, PDS Biotechnology Corporation, Vaccibody AS, Roche, EMD Serono, Eli Lilly and Company, Akeso Biopharma, Regeneron Pharmaceuticals, and others
• Key Cervical Cancer Therapies: RTX 321, DeTIL 0255, PDS 0101, VB10.16, Tiragolumab, Bintrafusp alfa, Gemcitabine, Cadonilimab, Cemiplima, and others
• Cervical Cancer Therapeutic Assessment: Cervical Cancer current marketed and Cervical Cancer emerging therapies
• Cervical Cancer Market Dynamics: Cervical Cancer market drivers and Cervical Cancer market barriers
Request for Sample PDF Report for Cervical Cancer Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Cervical Cancer Report Introduction
2 Cervical Cancer Executive Summary
3 Cervical Cancer Overview
4 Cervical Cancer- Analytical Perspective In-depth Commercial Assessment
5 Cervical Cancer Pipeline Therapeutics
6 Cervical Cancer Late Stage Products (Phase II/III)
7 Cervical Cancer Mid Stage Products (Phase II)
8 Cervical Cancer Early Stage Products (Phase I)
9 Cervical Cancer Preclinical Stage Products
10 Cervical Cancer Therapeutics Assessment
11 Cervical Cancer Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Cervical Cancer Key Companies
14 Cervical Cancer Key Products
15 Cervical Cancer Unmet Needs
16 Cervical Cancer Market Drivers and Barriers
17 Cervical Cancer Future Perspectives and Conclusion
18 Cervical Cancer Analyst Views
19 Appendix
20 About DelveInsight
Download Sample PDF Report to know more about Cervical Cancer drugs and therapies- https://www.delveinsight.com/sample-request/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports
Cervical Cancer Market https://www.delveinsight.com/report-store/cervical-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Cervical Cancer-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Cervical Cancer Epidemiology https://www.delveinsight.com/report-store/cervical-cancer-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Cervical Cancer Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cervical Cancer Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2828217 • Views: …
More Releases from DelveInsight Business Research
Global Patient Engagement Solutions Market to reach USD 59,499.28 million by 203 …
According to DelveInsight's analysis, The growth of the patient engagement solutions market is primarily fueled by several major factors, including the increasing burden of chronic conditions such as diabetes and cardiovascular diseases, which require continuous patient involvement and monitoring. The industry is further propelled by the move toward patient-centric healthcare models, ongoing technological innovations, and the introduction of new digital tools and platforms. Moreover, supportive government policies and initiatives aimed…
Global Magnetic Resonance Imaging Devices Market to reach USD 13,553.33 million …
According to DelveInsight's analysis, The growing incidence of chronic illnesses-including heart disease, cancer, and neurological disorders is driving demand for advanced diagnostic methods such as MRI, which provides highly detailed imaging of soft tissues and internal organs. Increasing awareness and a stronger focus on early disease detection are also prompting both patients and healthcare professionals to rely on MRI for faster and more accurate diagnosis. In addition, ongoing technological progress…
Global Microbial Fermentation Technology Market Size was USD 33,956.10 million i …
According to DelveInsight's analysis, The microbial fermentation technology market is experiencing strong growth, largely due to the increasing incidence of chronic illnesses such as cancer and a range of infectious diseases, including HIV, hepatitis B and C, and influenza. The market is also being boosted by the rising need for advanced therapeutic products like cell therapies, monoclonal antibodies, recombinant proteins, and gene therapies. Moreover, progress in synthetic biology and precision…
Global Surgical Robotic System Market to reach USD 29,785.13 million by 2032 at …
According to DelveInsight's analysis, The growing prevalence of chronic illnesses such as cancer, cardiovascular diseases, and orthopedic disorders is driving demand for advanced surgical solutions, which in turn is accelerating the expansion of the surgical robotic systems market. Since many of these conditions require complex, highly precise procedures, robotic-assisted surgery is becoming a preferred option due to its superior precision, less invasive nature, and faster patient recovery. At the same…
More Releases for Cervical
Increasing Cervical And Back Pain Prevalence Drives Demand For Cervical Pillows: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Cervical Pillows Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for cervical pillows has been experiencing consistent growth. The market is projected to expand from a value of $4.17 billion in 2024 to $4.37 billion in 2025, exhibiting a compound annual growth…
Increasing Cervical And Back Pain Prevalence Drives Demand For Cervical Pillows: …
"What market dynamics are playing a key role in accelerating the growth of the cervical pillows market?
The surge in incidence of cervical and back pain is predicted to boost the growth of the cervical pillows market. Such pains often afflict the neck and upper spine, resulting in discomfort and disturbed sleep. The increasing occurrence of these problems is linked to elements like a stationary lifestyle, amplified use of electronic gadgets,…
Cervical Cancer Screening Cervical Cancer Screening Market 2024 Global Share, Ke …
Global Cervical Cancer Screening Market 2024 Research report is segmented into several key regions, with production, consumption, revenue (million USD), market share and growth rate of Cervical Cancer Screening Industry in these regions, from 2024 to 2030 (forecast), covering North America, Europe, Asia Pacific, Middle East & Africa, South & Central America.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPBT00002661/?utm_source=OpenPR&utm_medium=10759
Key Players Analysis:
Abbott
Hologic Corporation
Qiagen N.V.
F Hoffmann-La Roche
Quest Diagnostics
BD
OncoHealth Corp.
Femasys, Inc.
TruScreen
Onko Solutions
The report covers key…
India Cervical Cancer Screening Market India Cervical Cancer Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Overview of the Cervical Cancer
1.1 Introduction
1.2 Stages of the Cervical Cancer
1.2.1 Stage 0
1.2.2 Stage 1
1.2.3 Stage 2
1.2.4 Stage 3
1.2.5 Stage 4
Occurrence Rate of the Cervical Cancer
2.1 Incidence of the Cervical Cancer in Indian States
…
Global Cervical Cancer Diagnostic Testing Devices Market 2017, Global Cervical C …
Focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer
Global Bronchoscopic Devices Market 2017, presents a professional and in-depth study on the current state of the Bronchoscopic Devices market globally, providing basic overview of Bronchoscopic Devices market including definitions, classifications, applications and industry chain structure, Bronchoscopic Devices Market report provides development policies and plans are discussed as well as manufacturing processes and cost…
North America Cervical Dysplasia Market grows with rising awareness about cervic …
Global Cervical Dysplasia Market: Snapshot
Cervical dysplasia is one of the fastest growing market in the field of cancer diagnosis and treatment. Cervical cancer is a precancerous stage and it can be completely cured by early detection. Rising consumer awareness in this regard has led to an increased demand for cervical screenings in the past few years. Government bodies in several developed countries conduct screening programs in order to improve…
